Reward-related brain response and craving correlates of marijuana cue exposure: A preliminary study in treatment-seeking marijuana-dependent subjects

Journal of Addiction Medicine

Volumn 7, Issue 1, 2013, Pages 8-16

  Goldman, Marina ^a   Szucs Reed, Regina P ^a   Jagannathan, Kanchana ^a   Ehrman, Ronald N ^b   Wang, Ze ^a   Li, Yin ^a   Suh, Jesse J ^a,b   Kampman, Kyle ^a   O'Brien, Charles P ^a,b   Childress, Anna Rose ^a,b   Franklin, Teresa R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; Brain reward circuitry; Cannabis; Craving; Marijuana cues; Neuroimaging

Indexed keywords

COCAINE; DIAMORPHINE; NICOTINE;

ADULT; ALCOHOLISM; AMYGDALOID NUCLEUS; ARTICLE; ASSOCIATION; BOLD SIGNAL; BRAIN FUNCTION; BRAIN REGION; CANNABIS ADDICTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; EXPOSURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HELP SEEKING BEHAVIOR; HEROIN DEPENDENCE; HIPPOCAMPUS; HUMAN; MALE; MARIJUANA CRAVING QUESTIONNAIRE SHORT FORM; MOTIVATION; NUCLEAR MAGNETIC RESONANCE SCANNER; ORBITAL CORTEX; PRIORITY JOURNAL; QUESTIONNAIRE; REWARD; SELF REPORT; TOBACCO DEPENDENCE; VISUAL STIMULATION; WITHDRAWAL SYNDROME;

ADULT; AMYGDALA; BEHAVIOR, ADDICTIVE; BRAIN MAPPING; CUES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHOTIC STIMULATION; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TECHNIQUES; RECURRENCE; REWARD; SUBSTANCE ABUSE DETECTION;

EID: 84877935392     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318273863a     Document Type: Article

References (55)

1. Asbridge M, Poulin C, Donato A. Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. Accid Anal Prev 2005;37(6): 1025-1034.
2. Boileau I, Dagher A, Leyton M, et al. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci 2007;27(15): 3998-4003.
3. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology 2002;59(9): 1337-1343.
4. Bonson KR, Grant SJ, Contoreggi CS, et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002;26(3): 376-386.
5. Bordnick PS, Copp HL, Traylor A, et al. Reactivity to cannabis cues in virtual reality environments. J Psychoactive Drugs 2009;41(2): 105-112.
6. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004;161(11): 1967-1977.
7. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002;26(3): 321-352.
8. Childress AR, Ehrman RN, Wang Z, et al. Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One 2008;3(1):e1506.
9. Childress AR, Hole AV, Ehrman RN, Robbins SJ, Mc Lellan AT, , O'Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 1993;137: 73-95.
10. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999;156(1): 11-18.
11. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. [See comment]. JAMA 2004;291(17): 2114-2121.
12. Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 1997;106(2): 243-250.
13. Copeland J, Swift W, Roffman R, Stephens R. Arandomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat 2001;21(2): 55-64; Discussion 65-56.
14. Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW. Neural responses associated with cue-reactivity in frequent cannabis users [published online ahead of print January 20, 2012]. Addict Biol doi: 10. 1111/j. 1369-1600. 2011. 00417.
15. Dagher A, Tannenbaum B, Hayashi T, Pruessner JC, McBride D. An acute psychosocial stress enhances the neural response to smoking cues. Brain Res 2009;1293: 40-48.
16. Denis C, Lavie E, Fatseas M, Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst Rev 2006 Jul 19;(3):CD005336.
17. DiChiara G, Tanda G, Bassareo V, et al. Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 1999;877: 461-485.
18. Elliott R, Dolan RJ, Frith CD. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex 2000;10(3): 308-317.
19. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Marijuana craving in the brain. Proc Natl Acad Sci U S A 2009;106(31): 13016-13021.
20. Franklin TR, Allen SS. Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction 2009;104(11): 1941-1942.
21. Franklin TR, Lohoff FW, Wang Z, et al. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 2009;34(3): 717-728.
22. Franklin TR, Wang Z, Li Y, et al. Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol 2011;16(2): 308-322.
23. Franklin TR, Wang Z, Wang J, et al. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 2007;32(11): 2301-2309.
24. Gellermann LW. Chance orders of alternating stimuli in visual discrimination experiments. J Gen Psychol 1933;42: 206-208.
25. Grant S, London ED, Newlin DB, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci US A 1996;93(21): 12040-12045.
26. Gray KM, LaRowe SD, Watson NL, Carpenter MJ. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav 2011;36(1/2): 140-143.
27. Haney M, Hart CL, Vosburg SK, et al. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology 2010;211(2): 233-244.
28. Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry 2008;69(9): 1354-1363.
29. Heinz A, Beck A, Grusser SM, Grace AA, Wrase J. Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 2009;14(1): 108-118.
30. Heishman SJ, Evans RJ, Singleton EG, Levin KH, Copersino ML, Gorelick DA. Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend 2009;102(1-3): 35-40.
31. Janes AC, Pizzagalli DA, Richardt S, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 2010;67(8): 722-729.
32. Langleben DD, Ruparel K, Elman I, et al. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry 2008;165(3): 390-394.
33. Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 2011;116(1-3): 142-150.
34. Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend 2009;105(1/2): 24-32.
35. Naqvi NH, Bechara A. The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct Funct 2010;214(5/6): 435-450.
36. Nordstrom BR, Levin FR. Treatment of cannabis use disorders: a review of the literature. Am J Addict 2007;16(5): 331-342.
37. O'Brien C, Pa T J. Conditioning as a cause of relapse in narcotic addiction. In: Gottheil EL, McLellan AT, Dudley KA, Alterman AI, eds. Addiction Research and Treatment: Converging Trends. New York: Pergamon Press; 1978;124-132.
38. Oslin DW, Cary M, Slaymaker V, Colleran C, Blow FC. Daily ratings measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking. Drug Alcohol Depend 2009;103(3): 131-136.
39. Payne TJ, Smith PO, Adams SG, Diefenbach L. Pretreatment cue reactivity predicts end-of-treatment smoking. Addict Behav 2006;31(4): 702-710.
40. Perkins KA, Marcus MD, Levine MD, et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weightconcerned women. J Consult Clin Psychol 2001;69(4): 604-613.
41. Preston KL, Vahabzadeh M, Schmittner J, Lin JL, Gorelick DA, Epstein DH. Cocaine craving and use during daily life. Psychopharmacology (Berl) 2009;207(2): 291-301.
42. Raphael B, Wooding S, Stevens G, Connor J. Comorbidity: cannabis and complexity. J Psychiatr Pract 2005;11(3): 161-176.
43. SAMHSA (2005). "Results from the 2004 National Survey on Drug Use and Mental Health. " DHHS Publication No. SMA 05-4062 NSDUH Series H-28. http://www. samhsa. gov/data/nsduh/2k4nsduh/2k4results/2k4results. pdf. Accessed January 16, 2012.
44. Sharma D, Money S. Carryover effects to addiction-associated stimuli in a group of marijuana and cocaine users. J Psychopharmacol 2010;24(9): 1309-1316.
45. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M. I. N. I. ): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20): 22-33; Quiz 34-57.
46. Singleton EG, Trotman AJ, Zavahir M, Taylor RC, Heishman SJ. Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. Exp Clin Psychopharmacol 2002;10(1): 47-53.
47. Sinha R, Li CS. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 2007;26(1): 25-31.
48. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 2001;124(Pt 9): 1720-1733.
49. Tang DW, Fellows LK, Small DM, Dagher A. Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol Behav 2012;106(3): 317-324.
50. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987;135(1): 209-216.
51. Tirado CF, Goldman M, Lynch K, Kampman KM, Obrien CP. Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study. Drug Alcohol Depend 2008;94(1-3): 254-257.
52. Volkow ND, Wang GJ, Telang F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006;26(24): 6583-6588.
53. Waters AJ, Sayette MA, Franken IH, Schwartz JE. Generalizability of carryover effects in the emotional Stroop task. Behav Res Ther 2005;43(6): 715-732.
54. Wechsler D. WASI Manual. San Antonio, TX: Psychological Corporation; 1999.
55. Wilson SJ, Sayette MA, Fiez JA, Brough E. Carry-over effects of smoking cue exposure on working memory performance. Nicotine Tob Res 2007;9(5): 613-619.